← Back to all trials
Active Not Recruiting
NCT06012656
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Conditions: Primary Osteoarthritis, Secondary Osteoarthritis, Traumatic Arthritis, Rheumatoid Arthritis, Congenital Hip Dysplasia, Avascular Necrosis, Fracture; Femur, Head
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: Medacta International SA
Location: Centre Clinical Angouleme Soyaux Soyaux France
Summary
This is a post-marketing surveillance on MiniMAX Stem
Eligibility Criteria
Inclusion Criteria:
1. Patient with a clinical condition requiring THA
2. Patient receiving a MiniMAX® stem
3. Patient aged more than 18 years
4. Patient having a Social Insurance or a similar protection regime
5. Patient eligible for an AMIS procedure
6. Patient able to follow the study requirements
7. Patients who are willing to give informed written consent
Exclusion Criteria:
1. Patient with local or systemic infection
2. Participation to biomedical research
3. Patient whose BMI exceeds 40
4. Patient with less than 18 years
5. Protected adults
6. Vulnerable person according to article L1121-6 of the Code de la Santè Publique.
7. Pregnant or lactating woman
8. Patient unable to express his/ her opinion about the participation to the study
Source: ClinicalTrials.gov (NCT06012656). StuddyBuddy aggregates publicly available trial information.
